The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey

Takumi Kawaguchi(Kurume University), Michio Sata(Kurume University), Toshihiko Mizuta(Saga University), Tatsuki Ichikawa(Nagasaki University), Kazuhiko Nakao(Nagasaki University), Makoto Nakamuta(Nagasaki Medical Center), Koichi Honda(Yamagata University), Yasushi Ide(Saga University), Masataka Seike(Oita University), Motoyuki Kohjima(Nagasaki Medical Center)
Journal of Gastroenterology
June 10, 2014
10.1007/s00535-014-0968-5
Cited by 19

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424